- 全部删除
- 您的购物车当前为空
Anti-IL-17RC Antibody (7K911) 是一种 Mouse 抗体,靶向 IL-17RC。Anti-IL-17RC Antibody (7K911) 可用于 ELISA。
Anti-IL-17RC Antibody (7K911) 是一种 Mouse 抗体,靶向 IL-17RC。Anti-IL-17RC Antibody (7K911) 可用于 ELISA。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 μL | ¥ 1,689 | 5日内发货 |
产品描述 | Anti-IL-17RC Antibody (7K911) is a Mouse antibody targeting IL-17RC. Anti-IL-17RC Antibody (7K911) can be used in ELISA. |
别名 | UNQ6118/PRO20040/PRO38901, interleukin 17 receptor C, IL17-RL, IL17RL |
Ig Type | Mouse IgG1 |
克隆号 | 7K911 |
交叉反应 | Human |
应用 | ELISA |
推荐剂量 | ELISA: 1:1000-1:2000 |
抗体种类 | Monoclonal |
宿主来源 | Mouse |
构建方式 | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human IL17RC (rh IL17RC; TMPY-02573; NP_116121.2; Met 1-Ala 454). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
研究背景 | IL17RC (Interleukin 17 Receptor C) is a Protein Coding gene. This gene encodes a single-pass type I membrane protein that shares similarity with the interleukin-17 receptor (IL-17RA). IL17RC is widely expressed in the prostate, skin, and other tissues. The hypomethylation within the IL17RC gene promoter in peripheral blood is not suitable for use as a clinical biomarker of AMD. This study highlights the need for considerable replication of epigenetic association studies before clinical application. methylation of IL17RC could play as a marker in choroidal neovascularization (CNV) and degeneration of retinal pigment epithelium (RPE) cells in vitro. Diseases associated with IL17RC include Candidiasis, Familial, 9, and Chronic Mucocutaneous Candidiasis. |
偶联 | Unconjugated |
免疫原 | Recombinant Protein: Human IL17RC protein (TMPY-02573) |
抗原种属 | Human |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
运输方式 | Shipping with blue ice. |
评论内容